| Patient |
1 |
2 |
3 |
4 |
| Age (y) |
60 |
59 |
63 |
55 |
| Gender |
Male |
Male |
Male |
Male |
| Diagnosis |
MM |
MM |
MDS |
MM |
| Conditioning treatment |
TBI (2 Gy) |
Fludarabine, Cyclofosfamide |
Fludarabine, TBI (2 Gy) |
TBI (2 Gy) |
| Allo-RIC donor |
HLA-matched sibling |
HLA identical sibling |
HLA identical sibling |
HLA identical sibling |
| Serum triglycerides (mmol/L) at baseline |
2.9 |
2.1 |
4.7 |
2.2 |
| Body weight (kg) |
82.0 |
74.7 |
68.4 |
96.8 |
| Diarrhoea (mL/24 h) |
1000 |
500 |
500-1000 |
700 |
| GVHD Liver |
B |
A |
B |
A |
| GVHD Skin |
A |
A |
A |
A |
| Amylase (U/L)1 |
102 |
95 |
34 |
70 |
| Lipase (U/L)1 |
56 |
26 |
28 |
42 |
| ALAT (U/L)1 |
94 |
63 |
112 |
131 |
| ASAT (U/L)1 |
39 |
82 |
72 |
70 |
| GGT (<U/L)1 |
776 |
300 |
1139 |
307 |
| AP (U/L)1 |
165 |
177 |
212 |
99 |
MM: Multiple Myeloma; MDS: Myelodysplastic Syndrome; TBI: Total Body Irradiation; RIC: Reduced Intensity Conditioning stem cell transplantation; HLA: Human
Leukocyte Antigen; GVHD: Graft-Versus-Host Disease; ALAT: Alanine Aminotransferase; ASAT: Aspartate Aminotransferase; GGT: Gamma Glutamyl Transferase; AP:
Alkaline Phosphatase.
1Reference values: amylase: <100 U/L, lipase: <70 U/L, ALAT: <50 U/L, ASAT: <45 U/L, GGT: <45 U/L, AP: <125 U/L. |
